Does the nadir growth-hormone level predict response to somatostatin-analogue therapy?
Nat Clin Pract Endocrinol Metab
.
2006 Jan;2(1):12-3.
doi: 10.1038/ncpendmet0072.
Authors
Albert Beckers
1
,
Adrian Daly
,
Patrick Petrossians
Affiliation
1
Department of Endocrinology, Centre Hospitalier Universitaire de Liège, University of Liège, Belgium.
[email protected]
PMID:
16932246
DOI:
10.1038/ncpendmet0072
No abstract available